Wechat|
Wechat |
| 2023, Vol. 30(2): 93-100 DOI: 10.3969/j.issn.1006-5253.2023.02.003 | ||
| Survival benefit analysis of postoperative adjuvant chemotherapy for early-stage NSCLC | ||
| Xu Lingyan，Li Qianni，Li Jian，Liu Meina | ||
| Department of Biostatistics, Harbin Medical University, Harbin 150081, China | ||
| Received 2022-09-26 Revised null | ||
| Supporting info | ||
|
|